About the Ozempic / GLP-1 Medications litigation
GLP-1 receptor agonists — including semaglutide (Ozempic, Wegovy) and similar medications — have been widely prescribed for type 2 diabetes and weight loss. These drugs slow the rate at which the stomach empties, and for some patients that effect has allegedly become severe and lasting.
Lawsuits allege that manufacturers failed to adequately warn about the risk of gastroparesis (stomach paralysis), ileus, intestinal obstruction, and cyclic vomiting syndrome. Some patients report hospitalization, feeding-tube placement, and long-term digestive damage.
If you took a GLP-1 medication and were diagnosed with gastroparesis, a bowel obstruction, or another serious gastrointestinal injury, you may qualify to file a claim. Complete our short intake to find out.